These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


254 related items for PubMed ID: 2859245

  • 1. [Changes in and modulation of receptor activity in hepatic encephalopathy].
    Kienzl E, Riederer P, Brücke T, Kleinberger G, Jellinger K.
    Infusionsther Klin Ernahr; 1985 Feb; 12(1):32, 37-45. PubMed ID: 2859245
    [Abstract] [Full Text] [Related]

  • 2. The GABA hypothesis of the pathogenesis of hepatic encephalopathy: current status.
    Jones EA, Schafer DF, Ferenci P, Pappas SC.
    Yale J Biol Med; 1984 Feb; 57(3):301-16. PubMed ID: 6093394
    [Abstract] [Full Text] [Related]

  • 3. Brain monoamines in hepatic encephalopathy and other types of metabolic coma.
    Jellinger K, Riederer P, Rausch WD, Kothbauer P.
    J Neural Transm Suppl; 1978 Feb; (14):103-20. PubMed ID: 39973
    [Abstract] [Full Text] [Related]

  • 4. [Ammonia and GABA-ergic neurotransmission in pathogenesis of hepatic encephalopathy].
    Helewski K, Kowalczyk-Ziomek G, Konecki J.
    Wiad Lek; 2003 Feb; 56(11-12):560-3. PubMed ID: 15058165
    [Abstract] [Full Text] [Related]

  • 5. Influence of supidimide on brain neurotransmitter systems of rats and mice.
    Hennies HH, Günzler WA, Flohé L.
    Arzneimittelforschung; 1984 Feb; 34(11):1471-80. PubMed ID: 6084511
    [Abstract] [Full Text] [Related]

  • 6. [Antagonism of the ammonia effect on serotonin receptors by L-valine].
    Kienzl E, Riederer P, Jellinger K, Kleinberger G.
    Leber Magen Darm; 1982 Oct; 12(5):179-81. PubMed ID: 7182696
    [Abstract] [Full Text] [Related]

  • 7. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.
    Leysen JE, Gommeren W, Van Gompel P, Wynants J, Janssen PF, Laduron PM.
    Mol Pharmacol; 1985 Jun; 27(6):600-11. PubMed ID: 2860558
    [Abstract] [Full Text] [Related]

  • 8. Gamma-aminobutyric acid and benzodiazepine receptors in an animal model of fulminant hepatic failure.
    Schafer DF, Fowler JM, Munson PJ, Thakur AK, Waggoner JG, Jones EA.
    J Lab Clin Med; 1983 Dec; 102(6):870-80. PubMed ID: 6315836
    [Abstract] [Full Text] [Related]

  • 9. 5-HT receptor regulation of neurotransmitter release.
    Fink KB, Göthert M.
    Pharmacol Rev; 2007 Dec; 59(4):360-417. PubMed ID: 18160701
    [Abstract] [Full Text] [Related]

  • 10. Pentylenetetrazole-induced seizures affect binding site densities for GABA, glutamate and adenosine receptors in the rat brain.
    Cremer CM, Palomero-Gallagher N, Bidmon HJ, Schleicher A, Speckmann EJ, Zilles K.
    Neuroscience; 2009 Sep 29; 163(1):490-9. PubMed ID: 19345722
    [Abstract] [Full Text] [Related]

  • 11. Differential effects of ammonia on the benzodiazepine modulatory site on the GABA-A receptor complex of human brain.
    Ahboucha S, Araqi F, Layrargues GP, Butterworth RF.
    Neurochem Int; 2005 Jul 29; 47(1-2):58-63. PubMed ID: 15913842
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Metabolic principles in hepatic encephalopathy].
    Gerok W.
    Internist (Berl); 1985 Jul 29; 26(7):377-87. PubMed ID: 2863233
    [No Abstract] [Full Text] [Related]

  • 14. Human cerebral free amino acids in hepatic coma.
    Weiser M, Riederer P, Kleinberger G.
    J Neural Transm Suppl; 1978 Jul 29; (14):95-102. PubMed ID: 290746
    [Abstract] [Full Text] [Related]

  • 15. Chlormethiazole--mode of action.
    Ogren SO.
    Acta Psychiatr Scand Suppl; 1986 Jul 29; 329():13-27. PubMed ID: 2875615
    [Abstract] [Full Text] [Related]

  • 16. Neuroactive amino acids and glutamate (NMDA) receptors in frontal cortex of rats with experimental acute liver failure.
    Michalak A, Rose C, Butterworth J, Butterworth RF.
    Hepatology; 1996 Oct 29; 24(4):908-13. PubMed ID: 8855196
    [Abstract] [Full Text] [Related]

  • 17. 5-hydroxytryptamine-moduline, a new endogenous cerebral peptide, controls the serotonergic activity via its specific interaction with 5-hydroxytryptamine1B/1D receptors.
    Massot O, Rousselle JC, Fillion MP, Grimaldi B, Cloëz-Tayarani I, Fugelli A, Prudhomme N, Seguin L, Rousseau B, Plantefol M, Hen R, Fillion G.
    Mol Pharmacol; 1996 Oct 29; 50(4):752-62. PubMed ID: 8863819
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Postsynaptic 5-HT(1A) receptors mediate an increase in locomotor activity in the monoamine-depleted rat.
    Mignon L, Wolf WA.
    Psychopharmacology (Berl); 2002 Aug 29; 163(1):85-94. PubMed ID: 12185404
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.